AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Core Laboratories N.V.

$12.36 -$4.59 (-27.11%)
NYSE · 15 Sep 2026 16:15 UTC
Previous Close
$12.22
Day Range
$12.23$12.48
Year Range
$9.79$20.36
Market Cap
569.52M
AVG Volume
730.27K
Trailing/Forward PE
22.06/16.8
PEG ratio
0.36
Dividend Yield
0.32%
Next Earnings Date
2026-10-28
Primary Exchange
New York Stock ExchangeUS
Revenue (USD)
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q2124.61M
26 Q1121.8M
25 Q4138.25M
25 Q3134.52M
25 Q2130.16M
25 Q1123.58M
24 Q4129.24M
24 Q3134.4M
24 Q2130.58M
24 Q1129.64M
Net Income (USD)
-5M05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q25.96M
26 Q1-789K
25 Q44.95M
25 Q314.24M
25 Q210.64M
25 Q1-154K
24 Q47.4M
24 Q311.74M
24 Q29.03M
24 Q13.22M
Operating Income (USD)
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q29.15M
26 Q11.89M
25 Q416.07M
25 Q320.93M
25 Q215.29M
25 Q14.42M
24 Q414.17M
24 Q319.8M
24 Q216.01M
24 Q18.57M
EBITDA (USD)
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q212.98M
26 Q15.65M
25 Q419.5M
25 Q324.52M
25 Q222.68M
25 Q18.13M
24 Q417.84M
24 Q323.48M
24 Q219.78M
24 Q112.41M
Cash Flows (USD)
-5M05M10M15M20M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q22.04M
26 Q1-926K
25 Q44.15M
25 Q35.47M
25 Q29.6M
25 Q13.08M
24 Q416.23M
24 Q310.37M
24 Q214.28M
24 Q12.48M
EPS (USD)
-0.100.10.20.324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.13
26 Q1-0.02
25 Q40.15
25 Q30.3
25 Q20.22
25 Q1-0
24 Q40.16
24 Q30.25
24 Q20.19
24 Q10.07
Expenses (USD)
05M10M15M20MSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q216.72M
26 Q119.61M
25 Q413.23M
25 Q313.72M
25 Q214.79M
25 Q117.23M
24 Q413.46M
24 Q311.05M
24 Q213.12M
24 Q114.84M
Cash & Debt (USD)
050M100M150M200MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q222.73M
26 Q122.82M
25 Q422.7M
25 Q325.63M
25 Q231.19M
25 Q122.11M
24 Q419.16M
24 Q321.47M
24 Q217.7M
24 Q114.91M
Debt ratios
012324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Debt ratios by quarter
PeriodDebt ratios
26 Q22.27
26 Q12
25 Q41.89
25 Q31.93
25 Q22.04
25 Q12.28
24 Q42.19
24 Q32.33
24 Q22.64
24 Q12.74
Margins
0%5%10%15%20%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Margins by quarter
PeriodMargins
26 Q218.65%
26 Q116.19%
25 Q418.13%
25 Q319.35%
25 Q217.51%
25 Q116.51%
24 Q414.99%
24 Q317.8%
24 Q218.29%
24 Q116.36%
Return on Capital
-2%0%2%4%6%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Return on Capital by quarter
PeriodReturn on Capital
26 Q22.14%
26 Q1-0.29%
25 Q41.82%
25 Q35.13%
25 Q23.98%
25 Q1-0.06%
24 Q42.87%
24 Q34.58%
24 Q23.68%
24 Q11.36%
Shares Outstanding
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Shares Outstanding by quarter
PeriodShares Outstanding
26 Q246.88M
26 Q146.07M
25 Q446.5M
25 Q347.08M
25 Q247.51M
25 Q146.77M
24 Q446.83M
24 Q346.92M
24 Q246.91M
24 Q146.86M
Dividends (USD)
00.511.5May 24Aug 24Nov 24Feb 25May 25Aug 25Nov 25Feb 26May 26Aug 26
CLB Dividends (USD) by quarter
PeriodDividends (USD)
Aug 260.01
May 260.01
Feb 260.01
Nov 250.01
Aug 250.01
May 250.01
Feb 250.01
Nov 240.01
Aug 240.01
May 240.01
Employee Count
01K2K3K4K202320242025
CLB Employee Count by quarter
PeriodEmployee Count
20253.3K
20243.5K
20233.6K
Book Value Per Share (USD)
024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q25.95
26 Q15.97
25 Q45.85
25 Q35.89
25 Q25.63
25 Q15.54
24 Q45.5
24 Q35.46
24 Q25.24
24 Q15.07
Total Assets (USD)
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
CLB Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q2586.78M
26 Q1587.73M
25 Q4584.01M
25 Q3591.36M
25 Q2602.11M
25 Q1591.52M
24 Q4590.41M
24 Q3600.47M
24 Q2597.8M
24 Q1587.95M
PE Ratio
10203040med 22.64Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CLB PE Ratio by quarter
PeriodPE Ratio
Sep 2623.52
Sep 2624.06
Sep 2624.14
Aug 2623.79
Aug 2624.1
Aug 2623.96
Aug 2621.85
Jul 2620.48
Jul 2618.52
Jul 2618
Jul 2617.61
Jul 2618.19
Jun 2617.49
Jun 2618.55
Jun 2620.88
Jun 2620.52
May 2621.69
May 2622.57
May 2620.74
May 2620.84
May 2622.33
Apr 2627.35
Apr 2625.86
Apr 2625.88
Apr 2625.59
Mar 2627.6
Mar 2623.76
Mar 2623.11
Mar 2623.32
Feb 2625.78
Feb 2626.99
Feb 2627.2
Feb 2627.2
Jan 2628.64
Jan 2628.52
Jan 2628.47
Jan 2627.8
Jan 2624.84
Dec 2523.98
Dec 2523.8
Dec 2524.15
Dec 2524.66
Nov 2522.13
Nov 2521.57
Nov 2522.55
Nov 2522.5
Oct 2523.36
Oct 2524.71
Oct 2518.18
Oct 2516.56
Oct 2519.47
Sep 2520.51
Sep 2519.19
Sep 2519.85
Sep 2520.24
Aug 2518.46
Aug 2517.91
Aug 2516.74
Aug 2516.39
Aug 2516.88
Jul 2518.81
Jul 2519.03
Jul 2521.46
Jul 2521.35
Jun 2519.59
Jun 2520.71
Jun 2520.14
Jun 2518.66
May 2517.94
May 2518.11
May 2519.78
May 2519.38
May 2520.59
Apr 2517.69
Apr 2518.82
Apr 2518.16
Apr 2517.93
Mar 2522.86
Mar 2522.86
Mar 2522.71
Mar 2522.15
Feb 2521.82
Feb 2524.07
Feb 2526.78
Feb 2529.7
Jan 2530.4
Jan 2534.93
Jan 2535.27
Jan 2532.24
Jan 2533.58
Dec 2429.98
Dec 2430.18
Dec 2434.82
Dec 2434.71
Nov 2436.45
Nov 2438.12
Nov 2434.98
Nov 2437.19
Nov 2433.85
Oct 2434.8
Free Cash Flow Yield
0%2%4%6%8%10%med 4.78%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CLB Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 261.87%
Sep 261.83%
Sep 261.83%
Aug 261.85%
Aug 261.83%
Aug 261.84%
Aug 262.02%
Jul 262.15%
Jul 263.4%
Jul 263.5%
Jul 263.58%
Jul 263.46%
Jun 263.6%
Jun 263.39%
Jun 263.02%
Jun 263.07%
May 262.9%
May 262.79%
May 263.04%
May 263.02%
May 262.82%
Apr 262.75%
Apr 262.91%
Apr 262.9%
Apr 262.94%
Mar 262.72%
Mar 264.51%
Mar 264.63%
Mar 264.59%
Feb 264.15%
Feb 263.96%
Feb 263.93%
Feb 263.93%
Jan 263.74%
Jan 263.75%
Jan 263.76%
Jan 263.85%
Jan 264.31%
Dec 254.46%
Dec 254.5%
Dec 254.43%
Dec 254.34%
Nov 254.84%
Nov 254.96%
Nov 254.75%
Nov 254.76%
Oct 254.58%
Oct 254.33%
Oct 257.29%
Oct 258%
Oct 256.81%
Sep 256.46%
Sep 256.91%
Sep 256.68%
Sep 256.55%
Aug 257.18%
Aug 257.4%
Aug 257.92%
Aug 258.09%
Aug 257.85%
Jul 257.05%
Jul 258.25%
Jul 257.31%
Jul 257.35%
Jun 258.01%
Jun 257.57%
Jun 257.79%
Jun 258.41%
May 258.74%
May 258.66%
May 257.93%
May 258.1%
May 257.62%
Apr 257.81%
Apr 257.34%
Apr 257.6%
Apr 257.7%
Mar 256.04%
Mar 256.04%
Mar 256.08%
Mar 256.24%
Feb 256.33%
Feb 255.74%
Feb 255.16%
Feb 255.65%
Jan 255.52%
Jan 254.81%
Jan 254.76%
Jan 255.21%
Jan 255%
Dec 245.6%
Dec 245.56%
Dec 244.82%
Dec 244.84%
Nov 244.61%
Nov 244.4%
Nov 244.8%
Nov 244.51%
Nov 244.96%
Oct 244.82%
Price to Sales
0.7511.251.51.752med 1.28Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CLB Price to Sales by quarter
PeriodPrice to Sales
Sep 261.1
Sep 261.13
Sep 261.13
Aug 261.12
Aug 261.13
Aug 261.12
Aug 261.02
Jul 260.96
Jul 261.02
Jul 261
Jul 260.97
Jul 261.01
Jun 260.97
Jun 261.03
Jun 261.16
Jun 261.14
May 261.2
May 261.25
May 261.15
May 261.15
May 261.24
Apr 261.54
Apr 261.46
Apr 261.46
Apr 261.44
Mar 261.56
Mar 261.47
Mar 261.43
Mar 261.45
Feb 261.6
Feb 261.68
Feb 261.69
Feb 261.69
Jan 261.78
Jan 261.77
Jan 261.77
Jan 261.73
Jan 261.54
Dec 251.49
Dec 251.48
Dec 251.5
Dec 251.53
Nov 251.37
Nov 251.34
Nov 251.4
Nov 251.4
Oct 251.45
Oct 251.53
Oct 251.04
Oct 250.95
Oct 251.11
Sep 251.17
Sep 251.1
Sep 251.14
Sep 251.16
Aug 251.06
Aug 251.03
Aug 250.96
Aug 250.94
Aug 250.97
Jul 251.08
Jul 251.03
Jul 251.16
Jul 251.16
Jun 251.06
Jun 251.12
Jun 251.09
Jun 251.01
May 250.97
May 250.98
May 251.07
May 251.05
May 251.11
Apr 251.06
Apr 251.13
Apr 251.09
Apr 251.07
Mar 251.37
Mar 251.37
Mar 251.36
Mar 251.33
Feb 251.31
Feb 251.44
Feb 251.61
Feb 251.49
Jan 251.52
Jan 251.75
Jan 251.77
Jan 251.62
Jan 251.68
Dec 241.5
Dec 241.51
Dec 241.74
Dec 241.74
Nov 241.83
Nov 241.91
Nov 241.75
Nov 241.86
Nov 241.7
Oct 241.74
EV/EBITDA
810121416med 11.63Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CLB EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2611.42
Sep 2611.63
Sep 2611.66
Aug 2611.52
Aug 2611.64
Aug 2611.59
Aug 2610.77
Jul 2610.23
Jul 269.44
Jul 269.23
Jul 269.07
Jul 269.3
Jun 269.02
Jun 269.45
Jun 2610.38
Jun 2610.24
May 2610.71
May 2611.06
May 2610.33
May 2610.37
May 2610.96
Apr 2612.73
Apr 2612.14
Apr 2612.15
Apr 2612.04
Mar 2612.83
Mar 2612.36
Mar 2612.08
Mar 2612.17
Feb 2613.25
Feb 2613.78
Feb 2613.87
Feb 2613.87
Jan 2614.51
Jan 2614.45
Jan 2614.43
Jan 2614.14
Jan 2612.84
Dec 2512.46
Dec 2512.38
Dec 2512.54
Dec 2512.76
Nov 2511.65
Nov 2511.4
Nov 2511.84
Nov 2511.81
Oct 2512.19
Oct 2512.78
Oct 259.51
Oct 258.85
Oct 2510.04
Sep 2510.47
Sep 259.93
Sep 2510.2
Sep 2510.36
Aug 259.62
Aug 259.4
Aug 258.92
Aug 258.77
Aug 258.98
Jul 259.77
Jul 259.98
Jul 2510.97
Jul 2510.92
Jun 2510.21
Jun 2510.67
Jun 2510.44
Jun 259.83
May 259.54
May 259.61
May 2510.29
May 2510.12
May 2510.62
Apr 259.75
Apr 2510.23
Apr 259.95
Apr 259.85
Mar 2511.96
Mar 2511.96
Mar 2511.89
Mar 2511.65
Feb 2511.51
Feb 2512.47
Feb 2513.63
Feb 2512.78
Jan 2513.03
Jan 2514.62
Jan 2514.74
Jan 2513.68
Jan 2514.15
Dec 2412.88
Dec 2412.95
Dec 2414.58
Dec 2414.55
Nov 2415.16
Nov 2415.74
Nov 2414.64
Nov 2415.42
Nov 2414.24
Oct 2414.58
Price/Operating Cashflow
510152025med 15.26Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CLB Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 2620.3
Sep 2620.76
Sep 2620.83
Aug 2620.53
Aug 2620.8
Aug 2620.68
Aug 2618.85
Jul 2617.67
Jul 2615.66
Jul 2615.22
Jul 2614.89
Jul 2615.38
Jun 2614.79
Jun 2615.69
Jun 2617.66
Jun 2617.35
May 2618.34
May 2619.08
May 2617.54
May 2617.62
May 2618.88
Apr 2621.91
Apr 2620.72
Apr 2620.73
Apr 2620.51
Mar 2622.11
Mar 2615.35
Mar 2614.94
Mar 2615.07
Feb 2616.66
Feb 2617.45
Feb 2617.58
Feb 2617.58
Jan 2618.51
Jan 2618.43
Jan 2618.4
Jan 2617.97
Jan 2616.06
Dec 2515.5
Dec 2515.38
Dec 2515.61
Dec 2515.94
Nov 2514.3
Nov 2513.94
Nov 2514.58
Nov 2514.54
Oct 2515.1
Oct 2515.97
Oct 259.92
Oct 259.04
Oct 2510.62
Sep 2511.19
Sep 2510.47
Sep 2510.83
Sep 2511.04
Aug 2510.07
Aug 259.77
Aug 259.14
Aug 258.94
Aug 259.21
Jul 2510.26
Jul 259.27
Jul 2510.46
Jul 2510.4
Jun 259.55
Jun 2510.09
Jun 259.82
Jun 259.09
May 258.74
May 258.82
May 259.64
May 259.44
May 2510.03
Apr 259.85
Apr 2510.48
Apr 2510.11
Apr 259.98
Mar 2512.73
Mar 2512.73
Mar 2512.65
Mar 2512.33
Feb 2512.15
Feb 2513.4
Feb 2514.91
Feb 2514.09
Jan 2514.42
Jan 2516.58
Jan 2516.74
Jan 2515.3
Jan 2515.94
Dec 2414.23
Dec 2414.32
Dec 2416.52
Dec 2416.47
Nov 2417.3
Nov 2418.09
Nov 2416.6
Nov 2417.65
Nov 2416.07
Oct 2416.52
Price to Book
1234med 2.44Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
CLB Price to Book by quarter
PeriodPrice to Book
Sep 262.05
Sep 262.1
Sep 262.11
Aug 262.08
Aug 262.11
Aug 262.09
Aug 261.91
Jul 261.79
Jul 261.95
Jul 261.9
Jul 261.86
Jul 261.92
Jun 261.85
Jun 261.96
Jun 262.2
Jun 262.17
May 262.29
May 262.38
May 262.19
May 262.2
May 262.36
Apr 262.98
Apr 262.82
Apr 262.82
Apr 262.79
Mar 263.01
Mar 262.75
Mar 262.68
Mar 262.7
Feb 262.99
Feb 263.13
Feb 263.15
Feb 263.15
Jan 263.32
Jan 263.3
Jan 263.3
Jan 263.22
Jan 262.88
Dec 252.78
Dec 252.76
Dec 252.8
Dec 252.86
Nov 252.56
Nov 252.5
Nov 252.61
Nov 252.61
Oct 252.71
Oct 252.86
Oct 252.02
Oct 251.84
Oct 252.16
Sep 252.27
Sep 252.13
Sep 252.2
Sep 252.24
Aug 252.05
Aug 251.99
Aug 251.86
Aug 251.82
Aug 251.87
Jul 252.08
Jul 252.06
Jul 252.32
Jul 252.31
Jun 252.12
Jun 252.24
Jun 252.18
Jun 252.02
May 251.94
May 251.96
May 252.14
May 252.09
May 252.23
Apr 252.15
Apr 252.29
Apr 252.21
Apr 252.18
Mar 252.79
Mar 252.79
Mar 252.77
Mar 252.7
Feb 252.66
Feb 252.93
Feb 253.26
Feb 253.03
Jan 253.11
Jan 253.57
Jan 253.6
Jan 253.29
Jan 253.43
Dec 243.06
Dec 243.08
Dec 243.56
Dec 243.55
Nov 243.72
Nov 243.89
Nov 243.57
Nov 243.8
Nov 243.46
Oct 243.56
Core Laboratories N.V.
CLB
Stockpicker

Video analysis: CLB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: CLB

3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges

zacks.com · 1 Sep 2026

3 Oilfield Services Stocks Poised to Gain Despite Industry Challenges

Strict capital discipline by upstream energy companies is acting as a dampener, making the outlook for the Zacks Oil and Gas-Field Services industry gloomy. FTI, OII and CLB are expected to survive the industry woes.

BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB

defenseworld.net · 30 Aug 2026

BlackRock Inc. Makes New Investment in Core Laboratories Inc. $CLB

BlackRock Inc. acquired a new stake in Core Laboratories Inc. (NYSE: CLB) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 7,460,118 shares of the oil and gas company's stock, valued at approximately $86,910,000. BlackRock Inc. owned 16.26% of Core Laboratories

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

zacks.com · 28 Aug 2026

Core Laboratories (CLB) Up 18.7% Since Last Earnings Report: Can It Continue?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock?

Advisors Capital Management LLC Makes New $2.77 Million Investment in Core Laboratories Inc. $CLB

defenseworld.net · 22 Aug 2026

Advisors Capital Management LLC Makes New $2.77 Million Investment in Core Laboratories Inc. $CLB

Advisors Capital Management LLC purchased a new stake in Core Laboratories Inc. (NYSE: CLB) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 237,398 shares of the oil and gas company's stock, valued at approximately $2,766,000. Advisors Capital Management LLC owned 0.52% of Core

John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value

gurufocus.com · 20 Aug 2026

John Rogers Buys Core Laboratories Inc (CLB) -- Shares Look 28% Undervalued on GF Value

On June 30, 2026, John Rogers (Trades, Portfolio), founder of Ariel Investment, LLC, increased the firm's stake in Core Laboratories Inc (NYSE: CLB) by 904,557 s

DTI or CLB: Which Is the Better Value Stock Right Now?

zacks.com · 11 Aug 2026

DTI or CLB: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Oil and Gas - Field Services sector might want to consider either Drilling Tools International Corp. (DTI) or Core Laboratories (CLB). But which of these two stocks is more attractive to value investors?

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

zacks.com · 31 Jul 2026

Is CLB Stock Attractive After Its Sharp Selloff and Mixed Q2 Results?

Core Laboratories stock looks cheaper after a 47.1% six-month selloff, but falling earnings and geopolitical pressure keep the near-term case cautious.

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

zacks.com · 31 Jul 2026

Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y

CLB's Q2 earnings top estimates despite lower revenues and profit as Production Enhancement strength offsets Reservoir Description weakness.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.